Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
YAMAU HOLDINGS, 7% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend
5284 YAMAU HOLDINGS CO., LTD. 【J-GAAP】
Earnings ReportYAMAU HOLDINGS CO., LTD. <5284> [TSE Std] announced its financial results after the market closed on May 8th (16:00). The consolidated ordinary profit for the fiscal year ending March 2025 expanded 38.8% from the previous period to 3.67 billion yen. However, for the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 7.5% from the previous period to 3.4 billion yen.
At the same time, the company increased the annual dividend for the previous term from 92 yen to 119 yen (compared to 86 yen in the prior term), and has decided to reduce the dividend this fiscal year to 103 yen, a decrease of 16 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 70.0% from the same period last year, reaching 1.31 billion yen. The operating profit margin jumped from 12.6% in the same period last year to 16.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 18,509 | 1,997 | 2,105 | 1,324 | 216.4 | 65 | May 10, 2023 | J-GAAP |
| Mar, 2024 | 19,745 | 2,582 | 2,647 | 1,737 | 283.9 | 86 | May 8, 2024 | J-GAAP |
| Mar, 2025 | 22,837 | 3,565 | 3,675 | 2,408 | 393.6 | 119 | May 8, 2025 | J-GAAP |
| YoY | +15.7% | +38.1% | +38.8% | +38.6% | +38.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 21,800 | 2,870 | 2,980 | 1,870 | 305.6 | 92 | Feb 7, 2025 | J-GAAP |
| Mar, 2025 Results | 22,837 | 3,565 | 3,675 | 2,408 | 393.6 | 119 | May 8, 2025 | J-GAAP |
| Revision Rate | +4.8% | +24.2% | +23.3% | +28.8% | +28.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 8,866 | 987 | 1,070 | 660 | 107.9 | 0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 9,000 | 900 | 950 | 580 | 95.7 | 0 | May 8, 2025 | J-GAAP |
| YoY | +1.5% | -8.8% | -11.2% | -12.1% | -11.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 19,745 | 2,582 | 2,647 | 1,737 | 283.9 | 86 | May 8, 2024 | J-GAAP |
| Mar, 2025 | 22,837 | 3,565 | 3,675 | 2,408 | 393.6 | 119 | May 8, 2025 | J-GAAP |
| Mar, 2026 Guidance | 22,400 | 3,350 | 3,400 | 2,100 | 346.6 | 103 | May 8, 2025 | J-GAAP |
| YoY | -1.9% | -6.0% | -7.5% | -12.8% | -11.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 6,091 | 765 | 771 | 501 | 81.9 | 12.6 | May 8, 2024 | J-GAAP |
| Apr - Jun, 2024 | 4,367 | 478 | 565 | 370 | 60.6 | 10.9 | Aug 2, 2024 | J-GAAP |
| Jul - Sep, 2024 | 4,499 | 509 | 505 | 290 | 47.4 | 11.3 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 6,104 | 1,267 | 1,294 | 845 | 138.1 | 20.8 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 7,867 | 1,311 | 1,311 | 903 | 147.6 | 16.7 | May 8, 2025 | J-GAAP |
| YoY | +29.2% | +71.4% | +70.0% | +80.2% | +80.3% |
Related Articles
Fuji Pharma, Jan-Mar (2Q) Ordinary Profit Decreases by 63%
FUKUDA DENSHI, Last Fiscal Year Ordinary Profit Revised Upward by 15%, Dividend Revised Upward by 25 yen
SUIDO KIKO KAISHA, 16% Increase in Ordinary Profit, Record High for The First Time in Five Years
Mie Kotsu, 1% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
KAWAMOTO, 47% Increase in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Ubicom Holdings, 2% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
CERES, Jan-Mar (1Q) Net Income Turns to Loss
TANAKA CHEMICAL, The Current Fiscal Year's Ordinary Loss to Widen
SIGMAXYZ Holdings, 20% Increase in Ordinary Profit, Update Record High for Fifth Consecutive Term, Dividend Raised by 5 yen
TSUKAMOTO, Last Fiscal Year Net Income Revised Downward to a Loss